Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Open accessThe DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
Many neurogenetic disorders are caused by the mutation of ubiquitously expressed genes. One such disorder, spinal muscular atrophy, is caused by loss or mutation of the survival motor neuron1 gene (SMN1), leading to reduced SMN protein levels and a selective dysfunction of motor neurons. SMN, together with partner proteins, functions in the assembly of small nuclear ribonucleoproteins (snRNPs), which are important for pre-mRNA splicing. It has also been suggested that SMN might function in the assembly of other ribonucleoprotein complexes. Two hypotheses have been proposed to explain the molecular dysfunction that gives rise to spinal muscular atrophy (SMA) and its specificity to a particular group of neurons. The first hypothesis states that the loss of SMN's well-known function in snRNP assembly causes an alteration in the splicing of a specific gene (or genes). The second hypothesis proposes that SMN is crucial for the transport of mRNA in neurons and that disruption of this function results in SMA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also of particular relevance is the possible role of HuD in spinal muscular atrophy (SMA), a disease that results in degeneration of spinal cord motor neurons due to deletion or loss-of-function mutations in the survival of motor neuron 1 (SMN1) gene, resulting in inadequate expression of functional SMN protein (Burghes and Beattie 2009).”
From Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction (2013) · cites this paper as Burghes and Beattie 2009
Experimental — accuracy not yet measuredIn the citing paper
“SMA is a devastating neurodegenerative disease resulting from progressive loss of motor neurons.1”
From Current clinical applications of in vivo gene therapy with AAVs (2021) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative isoform regulation in human tissue transcriptomes
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S. F., Schroth, G. P., & Burge, C. B. (2008) · Nature · doi:10.1038/nature07509 · Cited by 5,181
Identification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,532
Muscle Biopsy: A Practical Approach
Dubowitz, V., Sewry, C. A., Oldfors, A., & Lane, R. J. M. (2020) · Cited by 1,335
Molecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107 · cited 1×
“cgi?id=105400">amyotrophic lateral sclerosis (caused by mutations in superoxide dismutase 1 ( SOD1 )”
BackgroundCorrelation between severity and SMN protein level in spinal muscular atrophy
Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100
Feldkötter, M., Schwarzer, V., Wirth, R., Wienker, T. F., & Wirth, B. (2002) · The American Journal of Human Genetics · doi:10.1086/338627 · Cited by 1,004
Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 954
Self-citationNon-coding RNAs: lessons from the small nuclear and small nucleolar RNAs
Matera, A. G., Terns, R. M., & Terns, M. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2124 · Cited by 877
A novel nuclear structure containing the survival of motor neurons protein.
Liu, Q., & Dreyfuss, G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00725.x · Cited by 780
Cited by
Items 401–500 of 825
Spinal Muscular Atrophy Modeling and Treatment Advances by Induced Pluripotent Stem Cells Studies
Adami, R., & Bottai, D. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09910-6 · Cited by 19
Ontario Newborn Screening for Spinal Muscular Atrophy: The First Year
Kernohan, K. D., McMillan, H. J., Yeh, E., Lacaria, M., Kowalski, M., Campbell, C., Dowling, J. J., Gonorazky, H. D., Marcadier, J., Tarnopolsky, M. A., et al. (2021) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2021.231 · Cited by 19
Functional and structural deficiencies of Gemin5 variants associated with neurological disorders
Francisco‐Velilla, R., Buh, A. E., del Caño‐Ochoa, F., Abellan, S., Vilar, M., Álvarez, S., Fernández‐Jaén, A., Kour, S., Rajan, D. S., Pandey, U. B., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202201403 · Cited by 19
SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice
Gombash, S. E., Cowley, C. J., Fitzgerald, J. A., Iyer, C. C., Fried, D. E., McGovern, V. L., Williams, K. C., Burghes, A. H. M., Christofi, F. L., Gulbransen, B. D., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv292 · Cited by 19
Self-citationSchultz, J., Lee, S.-J., Cole, T., Hoang, H. D., Vibbert, J., Cottee, P. A., Miller, M. A., & Han, S. M. (2017) · Development · doi:10.1242/dev.152025 · Cited by 19
Different Stability and Proteasome-Mediated Degradation Rate of SMN Protein Isoforms
Locatelli, D., Terao, M., Kurosaki, M., Zanellati, M. C., Pletto, D. R., Finardi, A., Colciaghi, F., Garattini, E., & Battaglia, G. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134163 · Cited by 19
Progress in spinal muscular atrophy research
Wurster, C. D., & Petri, S. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001102 · Cited by 18
Deng, C., & Chen, H. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106377 · Cited by 18
Autophagy in spinal muscular atrophy: from pathogenic mechanisms to therapeutic approaches
Rashid, S., & Dimitriadi, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1307636 · Cited by 18
Shell, R. D., McGrattan, K. E., Hurst-Davis, R., Young, S. D., Baranello, G., Lavrov, A., O’Brien, E. J., Wallach, S., LaMarca, N. M., Reyna, S. P., et al. (2023) · Neuromuscular Disorders · doi:10.1016/j.nmd.2023.06.005 · Cited by 18
Wadman, R. I., Jansen, M. D., Curial, C. A. D., Groen, E. J. N., Stam, M., Wijngaarde, C. A., Medic, J., Sodaar, P., van Eijk, K. R., Huibers, M. M. H., et al. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000386 · Cited by 18
Gao, X., Teng, Y., Luo, J., Huang, L., Li, M., Zhang, Z., Ma, Y. C., & Ma, L. (2014) · RNA Biology · doi:10.4161/rna.36100 · Cited by 18
Nishio, H., Niba, E. T. E., Saito, T., Okamoto, K., Lee, T., Takeshima, Y., Awano, H., & Lai, P. S. (2024) · Genes · doi:10.3390/genes15101294 · Cited by 17
Faulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders
Pagliarini, V., Rosa, P. L., & Sette, C. (2017) · Human Genetics · doi:10.1007/s00439-017-1802-y · Cited by 17
Molecular Pathogenesis and New Therapeutic Dimensions for Spinal Muscular Atrophy
López‐Cortés, A., Echeverría‐Garcés, G., & Ramos-Medina, M. J. (2022) · Biology · doi:10.3390/biology11060894 · Cited by 17
High content analysis in amyotrophic lateral sclerosis
Rinaldi, F., Motti, D., Ferraiuolo, L., & Kaspar, B. K. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.12.001 · Cited by 17
Modelling motor neuron disease in fruit flies: Lessons from spinal muscular atrophy
Aquilina, B., & Cauchi, R. J. (2018) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2018.04.003 · Cited by 17
Electrocardiographic Evaluation in Patients With Spinal Muscular Atrophy: A Case-Control Study
Falsaperla, R., Vitaliti, G., Collotta, A. D., Fiorillo, C., Pulvirenti, A., Alaimo, S., Romano, C., & Ruggieri, M. (2018) · Journal of Child Neurology · doi:10.1177/0883073818767170 · Cited by 17
Functional characterization of SMN evolution in mouse models of SMA
Osman, E. Y., Bolding, M., Villalón, E., Kaifer, K. A., Lorson, Z. C., Tisdale, S., Hao, Y., Conant, G. C., Pires, J. C., Pellizzoni, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45822-8 · Cited by 17
ZPR1-Dependent Neurodegeneration Is Mediated by the JNK Signaling Pathway
Jiang, X., Kannan, A., & Gangwani, L. (2019) · Journal of Experimental Neuroscience · doi:10.1177/1179069519867915 · Cited by 17
Shaw, S. W., Peng, S.-Y., Liang, C., Lin, T., Cheng, P., Hsieh, T., Chuang, H.-Y., Coppi, P. D., & David, A. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-88559-z · Cited by 17
Composition of the Survival Motor Neuron (SMN) Complex in Drosophila melanogaster
Matera, A. G., Raimer, A. C., Schmidt, C. A., Kelly, J. A., Droby, G. N., Baillat, D., ten Have, S., Lamond, A. I., Wagner, E. J., & Gray, K. M. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200874 · Cited by 17
Chen, Y.-C., Chang, J., Jong, Y., Liu, T.-Y., & Yuo, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120721 · Cited by 16
CBP-mediated SMN acetylation modulates Cajal body biogenesis and the cytoplasmic targeting of SMN
Lafarga, V., Tapia, O., Sharma, S., Bengoechea, R., Stoecklin, G., Lafarga, M., & Berciano, M. T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2638-2 · Cited by 16
Park, M., Xu, X., Min, W., Sugiman‐Marangos, S. N., Beilhartz, G. L., Adams, J., Sidhu, S. S., Grunebaum, E., & Melnyk, R. A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00735 · Cited by 16
Nanopore Fabrication and Application as Biosensors in Neurodegenerative Diseases
Lenhart, B. J., Wei, X., Zhang, Z., Wang, X., Wang, Q., & Liu, C. (2020) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.2020033151 · Cited by 16
Pfeiffer-Guglielmi, B., Dombert, B., Jablonka, S., Hausherr, V., van Thriel, C., Schöbel, N., & Jansen, R. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-70 · Cited by 16
Arnold, W. D., Duqué, S. I., Iyer, C. C., Zaworski, P. G., McGovern, V. L., Taylor, S. J., von Herrmann, K. M., Kobayashi, D. T., Chen, K. S., Kolb, S. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167077 · Cited by 16
Self-citationGenetic screen identifies a requirement for SMN in mRNA localisation within the Drosophila oocyte
Aquilina, B., & Cauchi, R. J. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3496-1 · Cited by 15
Cottam, N. C., Bamfo, T., Harrington, M. A., Charvet, C. J., Hekmatyar, K., Tulin, N., & Sun, J. (2023) · Brain Pathology · doi:10.1111/bpa.13162 · Cited by 15
Cure SMA and our patient community celebrate the first approved drug for SMA
Glascock, J., Lenz, M., Hobby, K., & Jarecki, J. (2017) · Gene Therapy · doi:10.1038/gt.2017.39 · Cited by 15
Berciano, M. T., Castillo-Iglesias, M. S., Val‐Bernal, J. F., Lafarga, V., Rodríguez-Rey, J. C., Lafarga, M., & Tapia, O. (2020) · Cell and Tissue Research · doi:10.1007/s00441-020-03236-3 · Cited by 15
Conditional deletion of SMN in cell culture identifies functional SMN alleles
Blatnik, A. J., McGovern, V. L., Le, T. T., Iyer, C. C., Kaspar, B. K., & Burghes, A. H. M. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa229 · Cited by 15
Self-citationVarderidou‐Minasian, S., Verheijen, B. M., Harschnitz, O., Kling, S., Karst, H., van der Pol, W. L., Pasterkamp, R. J., & Altelaar, M. A. F. (2021) · ACS Omega · doi:10.1021/acsomega.1c04688 · Cited by 15
Kotulska, K., Chmielewski, D., Mazurkiewicz‐Bełdzińska, M., Tomaszek, K., Pierzchlewicz, K., Rabczenko, D., Przysło, Ł., Biedroń, A., Czyżyk, E., Steinborn, B., et al. (2022) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2022.06.001 · Cited by 15
VI Brazilian consensus guidelines for detection of anti-cell autoantibodies on HEp-2 cells
Cruvinel, W. D. M., Andrade, L. E. C., Dellavance, A., Ximenes, A. C., Bichara, C. D. A., Mangueira, C. L. P., Bonfá, E., Brito, F. D. A., Mariz, H. D. A., dos Anjos, L. M. E., et al. (2022) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-022-00266-z · Cited by 15
Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era
Querin, G., de la Banda, M. G. G., & Smeriglio, P. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1226969 · Cited by 15
Pruss, R. M., Giraudon‐Paoli, M., Morozova, S., Berna, P. P., Abitbol, J., & Bordet, T. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.228 · Cited by 15
Lee, J.-B., Lee, K., Hong, J., Suh, G. I., & Choi, Y. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2012.53.1.53 · Cited by 15
Saint-Marc, B., Elie, C., Manens, L., Tack, K., Benderitter, M., Guéguen, Y., & Ibanez, C. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.05.004 · Cited by 15
Mild SMN missense alleles are only functional in the presence of SMN2 in mammals
Iyer, C. C., Corlett, K. M., Massoni‐Laporte, A., Duqué, S. I., Madabusi, N. K., Tisdale, S., McGovern, V. L., Le, T. T., Zaworski, P. G., Arnold, W. D., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy251 · Cited by 15
Self-citationLa atrofia muscular espinal en el nuevo escenario terapéutico
Tizzano, E. F. (2018) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2018.08.001 · Cited by 15
Ali, I., Gilchrist, F. J., Carroll, W. D., Alexander, J., Clayton, S., Kulshrestha, R., Willis, T. A., & Samuels, M. P. (2019) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2019-000572 · Cited by 15
Poole, A. R., Enwerem-Lackland, I., Vicino, I., Coole, J. B., Smith, S. V., & Hebert, M. D. (2016) · RNA Biology · doi:10.1080/15476286.2016.1211224 · Cited by 15
Udina, E., Putman, C. T., Harris, L. R., Tyreman, N., Cook, V. E., & Gordon, T. (2016) · The Journal of Physiology · doi:10.1113/jp273404 · Cited by 15
SMA mutations in SMN Tudor and C-terminal domains destabilize the protein
Takarada, T., Rochmah, M. A., Harahap, N. I. F., Shinohara, M., Saito, T., Saito, K., Lai, P. S., Bouike, Y., Takeshima, Y., Awano, H., et al. (2017) · Brain and Development · doi:10.1016/j.braindev.2017.03.002 · Cited by 15
Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction
Torri, F., Mancuso, M., Siciliano, G., & Ricci, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137311 · Cited by 14
Tseng, Y., Jong, Y., Liang, W., Chang, F., & Lo, Y. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.08.018 · Cited by 14
Chiriboga, C. A. (2022) · Pediatric Drugs · doi:10.1007/s40272-022-00529-8 · Cited by 14
Aasdev, A., Sreelekshmi, R. S., Iyer, V. R., & Moharir, S. C. (2024) · Journal of Biosciences · doi:10.1007/s12038-023-00412-9 · Cited by 14
Iyer, C. C., McGovern, V. L., Wise, D. O., Glass, D. J., & Burghes, A. H. M. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.02.007 · Cited by 14
Self-citationMier, P., & Pérez‐Pulido, A. J. (2011) · Gene · doi:10.1016/j.gene.2011.10.006 · Cited by 14
Zhang, H., Robinson, N., Wu, C.-Y., Wang, W., & Harrington, M. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011696 · Cited by 14
Chung-Wei, Y., Chen, C., Chou, W., Lin, H.-C., Jong, Y., Tsai, L., & Chuang, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157426 · Cited by 14
Penrad‐Mobayed, M., Perrin, C., Herman, L., Todeschini, A., Nigon, F., Cosson, B., Caburet, S., & Veitia, R. A. (2019) · The FASEB Journal · doi:10.1096/fj.201901573r · Cited by 14
Sendtner, M. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-45106-5_15 · Cited by 13
Cui, Q., Wang, W., Namani, A., Wang, H., Hammad, A., Huang, P., Gao, Y., Elshaer, M., Wu, Y., Wang, X. J., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02799-z · Cited by 13
Nonmammalian Animal Models of Spinal Muscular Atrophy
O’Hern, P., Garcia, E. L., Hao, L. T., Hart, A. C., Matera, A. G., & Beattie, C. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803685-3.00014-8 · Cited by 13
Self-citationSMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities
Dominguez, C. E., Cunningham, D., & Chandler, D. S. (2017) · Human Genetics · doi:10.1007/s00439-017-1835-2 · Cited by 13
Blatnik, A. J., McGovern, V. L., & Burghes, A. H. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168494 · Cited by 13
Self-citationIdentification of the phosphorylation sites in the survival motor neuron protein by protein kinase A
Wu, C.-Y., Curtis, A., Choi, Y. S., Maeda, M., Xu, M. J., Berg, A., Joneja, U., Mason, R. W., Lee, K. H., & Wang, W. (2011) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.04.015 · Cited by 13
Alpha-Synuclein Loss in Spinal Muscular Atrophy
Acsádi, G., Li, X., Murphy, K. J., Swoboda, K. J., & Parker, G. C. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9422-1 · Cited by 13
RNA-Processing Dysfunction in Spinal Muscular Atrophy
Tisdale, S., & Pellizzoni, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803685-3.00007-0 · Cited by 13
Novel therapies for spinal muscular atrophy are likely changing the patient phenotype
Vu‐Han, T., Weiß, C., & Pumberger, M. (2020) · The Spine Journal · doi:10.1016/j.spinee.2020.08.013 · Cited by 12
The SMN-ribosome interplay: a new opportunity for Spinal Muscular Atrophy therapies
Sharma, G., Paganin, M., Lauria, F., Perenthaler, E., & Viero, G. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231116 · Cited by 12
Gassman, A., Hao, L. T., Bhoite, L. T., Bradford, C. L., Chien, C.-B., Beattie, C. E., & Manfredi, J. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074325 · Cited by 12
Self-citationThe Function of Survival Motor Neuron Complex and Its Role in Spinal Muscular Atrophy Pathogenesis
So, B. R., Zhang, Z., & Dreyfuss, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803685-3.00006-9 · Cited by 12
The SMA Trust: the role of a disease-focused research charity in developing treatments for SMA
Christie-Brown, V., Mitchell, J., & Talbot, K. (2017) · Gene Therapy · doi:10.1038/gt.2017.47 · Cited by 12
Interaction modulation through arrays of clustered methyl-arginine protein modifications
Woodsmith, J., Casado‐Medrano, V., Benlasfer, N., Eccles, R. L., Hutten, S., Heine, C. L., Thormann, V., Abou‐Ajram, C., Rocks, O., Dormann, D., et al. (2018) · Life Science Alliance · doi:10.26508/lsa.201800178 · Cited by 12
Splicing Defects of the Profilin Gene Alter Actin Dynamics in an S. pombe SMN Mutant
Antoine, M., Patrick, K. L., Soret, J., Duc, P., Rage, F., Cacciottolo, R., Nissen, K. E., Cauchi, R. J., Krogan, N. J., Guthrie, C., et al. (2019) · iScience · doi:10.1016/j.isci.2019.100809 · Cited by 12
Identification and structural analysis of the Schizosaccharomyces pombe SMN complex
Veepaschit, J., Viswanathan, A., Bordonné, R., Grimm, C., & Fischer, U. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab158 · Cited by 12
Lin, M., Hu, X., Chang, S., Chang, Y. Z., Bian, W., Hu, R., Wang, J., Zhu, Q., & Qiu, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6678422 · Cited by 12
SMN regulates GEMIN5 expression and acts as a modifier of GEMIN5-mediated neurodegeneration
Fortuna, T. R., Kour, S., Chimata, A. V., Muiños-Bühl, A., Anderson, E. N., Nelson, C., Ward, C., Chauhan, O., O’Brien, C., Rajasundaram, D., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02607-8 · Cited by 12
Spinal muscular atrophy: A new player joins the battle forSMN2exon 7 splicing
Pedrotti, S., & Sette, C. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13153 · Cited by 12
Regulatory roles of RNA binding proteins in the nervous system of C. elegans
Sharifnia, P., & Jin, Y. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00100 · Cited by 12
Yang, D., Zhu, L., Ren, J., Ma, R., Zhu, H., & Xu, J. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-015-1541-9 · Cited by 12
Rademacher, S., Detering, N. T., Schüning, T., Lindner, R. M., Santonicola, P., Wefel, I.-M., Dehus, J., Walter, L. M., Brinkmann, H., Niewienda, A., et al. (2020) · Cells · doi:10.3390/cells9112405 · Cited by 12
Common Pathways of Autoimmune Inflammatory Myopathies and Genetic Neuromuscular Disorders
Satoh, M., Ceribelli, A., & Chan, E. K. L. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-011-8286-7 · Cited by 12
A link between agrin signalling and Cav3.2 at the neuromuscular junction in spinal muscular atrophy
Delers, P., Sapaly, D., Salman, B., Waard, S. D., WAARD, M. M. D., & Lefebvre, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-23703-x · Cited by 11
Ros, L. A. A., Goedee, H. S., Franssen, H., Asselman, F., Bartels, B., Cuppen, I., van Eijk, R. P. A., Sleutjes, B. T. H. M., van der Pol, W. L., & Wadman, R. I. (2023) · BMC Neurology · doi:10.1186/s12883-023-03207-5 · Cited by 11
Glucose and Lipid Metabolism Disorders in Adults with Spinal Muscular Atrophy Type 3
Miletić, M., Stević, Z., Vujović, S., Rakočević, J., Tomic, A. M., Tančić‐Gajić, M., Stojanovic, M. M., Palibrk, A., & Žarković, M. (2024) · Diagnostics · doi:10.3390/diagnostics14182078 · Cited by 11
Mazzarella, N., Giangrieco, I., Visone, S., Santonicola, P., Achenbach, J., Zampi, G., Tamburrini, M., Schiavi, E. D., & Ciardiello, M. A. (2019) · Food Science & Nutrition · doi:10.1002/fsn3.1078 · Cited by 11
Orally administered branaplam does not impact neurogenesis in juvenile mice, rats, and dogs
Theil, D. J., Valdez, R., Darribat, K., Doelemeyer, A., Sivasankaran, R., & Hartmann, A. (2021) · Biology Open · doi:10.1242/bio.058551 · Cited by 11
Onodera, O., Ishihara, T., Shiga, A., Ariizumi, Y., Yokoseki, A., & Nishizawa, M. (2013) · Neuropathology · doi:10.1111/neup.12070 · Cited by 11
Genetics of Spinal Muscular Atrophy
Burghes, A. H. M., & McGovern, V. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802257-3.00006-7 · Cited by 11
Self-citationSplice-switching small molecules: A new therapeutic approach to modulate gene expression
Taladriz‐Sender, A., Campbell, E., & Burley, G. A. (2019) · Methods · doi:10.1016/j.ymeth.2019.06.011 · Cited by 10
Niba, E. T. E., Nishio, H., Wijaya, Y. O. S., Rochmah, M. A., Takarada, T., Takeuchi, A., Kimizu, T., Okamoto, K., Saito, T., Awano, H., et al. (2022) · Genes · doi:10.3390/genes13020205 · Cited by 10
Telomeric Region of the Spinal Muscular Atrophy Locus Is Susceptible to Structural Variations
Noguchi, Y., Ōnishi, A., Nakamachi, Y., Hayashi, N., Harahap, N. I. F., Rochmah, M. A., Shima, A., Yanagisawa, S., Morisada, N., Nakagawa, T., et al. (2016) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2016.01.019 · Cited by 10
Dachs, E., Piedrafita, L., Hereu, M., Esquerda, J. E., & Calderó, J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.026 · Cited by 10
Singh, M., Singh, S. P., Yadav, D., Agarwal, M., Agarwal, S., Agarwal, V., Swargiary, G., Srivastava, S., Tyagi, S., Kaur, R., et al. (2020) · Current Gene Therapy · doi:10.2174/1566523220999200817164907 · Cited by 10
Communicating the Spinal Muscular Atrophy diagnosis to children and the principle of autonomy
Fernandes, I. A. M., Menezes, R. O. A., & Rêgo, G. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03552-3 · Cited by 10
Mammalian Models of Spinal Muscular Atrophy
Burghes, A. H. M., DiDonato, C. J., McGovern, V. L., & Arnold, W. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803685-3.00015-x · Cited by 10
Self-citationSystematic literature review of the impact of spinal muscular atrophy therapies on bulbar function
McGrattan, K. E., Walsh, K., Mehl, L., Kaur, S., & Dilly, K. W. (2024) · Journal of Neuromuscular Diseases · doi:10.1177/22143602241303373 · Cited by 9
Ottoboni, L., Bruno, C., & Corti, S. P. (2025) · Brain · doi:10.1093/brain/awaf392 · Cited by 9
Li, W. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81887 · Cited by 9
Kong, L., Li, S., Zhao, Z., Feng, J., Fu, X., Li, H., Zhu, J., Wang, Y., Tang, W., Yuan, C., et al. (2023) · Clinical Genetics · doi:10.1111/cge.14434 · Cited by 9
Kubo, S., & Tanaka, Y. (2024) · Immunological Medicine · doi:10.1080/25785826.2024.2338593 · Cited by 9
Diving deep: zebrafish models in motor neuron degeneration research
Garg, V., & Geurten, B. R. H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1424025 · Cited by 9
The spinal muscular atrophy gene product regulates actin dynamics
Schüning, T., Zeug, A., Strienke, K., Franz, P., Tsiavaliaris, G., Hensel, N., Viero, G., Ponimaskin, E. G., & Claus, P. (2024) · The FASEB Journal · doi:10.1096/fj.202300183r · Cited by 9
Grice, S. J., & Liu, J. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010325 · Cited by 9
Metadata
- Authors
- Burghes, A. H. M., & Beattie, C. E.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Burghes, Arthur H. M.
- Venue
- Nature Reviews Neuroscience
- Published
- 2009-07-08
- Volume
- 10
- Issue
- 8
- Pages
- 597-609
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC2853768
- OpenAlex
- W2148071380
- Cited by
- 723
- References
- 176
- Citations by year
- 2026: 24 · 2025: 27 · 2024: 28 · 2023: 33 · 2022: 33 · 2021: 41 · 2020: 38 · 2019: 44 · 2018: 46 · 2017: 54 · 2016: 50 · 2015: 50 · 2014: 46 · 2013: 56 · 2012: 43
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS038650, R01NS041649)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- spinal muscular atrophy, survival motor neuron protein, SMN1, motor neuron dysfunction, small nuclear ribonucleoproteins, pre-mRNA splicing, ribonucleoprotein assembly, mRNA transport, loss-of-function mutations, neurodegeneration
- MeSH terms
- Humans, Models, Biological, Motor Neurons, Muscular Atrophy, Spinal, Ribonucleoproteins, Small Nuclear, Survival of Motor Neuron 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.